The Preimplantation Genetic Testing Market is becoming an important component of modern reproductive medicine as fertility specialists and genetics laboratories develop more advanced methods for evaluating embryos. PGT can provide information about selected genetic and chromosomal conditions before an embryo is transferred during an IVF cycle. Growing awareness of inherited disorders and improvements in molecular testing are helping expand the market.

PGT-M is particularly relevant for couples who have a known risk of passing a single-gene disorder to their children. The American Society for Reproductive Medicine states that PGT-M can be performed for most Mendelian conditions, although some cases may not be technically feasible and require customized laboratory development before an IVF cycle begins.

PGT-A represents another major application. It evaluates embryos for aneuploidy, or abnormal chromosome numbers. Although PGT-A is increasingly used, current clinical guidance emphasizes that its routine use for all IVF patients has not been demonstrated to provide universal benefit. Recent ASRM guidance notes that outcomes can vary according to patient and clinical circumstances.

The market is also being influenced by advances in sequencing technologies. Next-generation sequencing can support the analysis of genetic material obtained from embryo biopsies, while improved laboratory software and bioinformatics help process increasingly complex datasets. These developments are contributing to more sophisticated testing workflows.

Another emerging area is polygenic embryo testing. However, this technology remains scientifically and clinically uncertain. In its 2026 ethics opinion, ASRM concluded that PGT-P is not ready for clinical use and should not currently be offered as a clinical service.

As reproductive genetics continues to advance, market growth is expected to be driven by IVF utilization, genetic disease awareness, laboratory innovation, and improved access to specialized reproductive services. At the same time, clinical evidence, ethical standards, and appropriate genetic counseling will remain central to responsible market development.

Gain a competitive edge with insightful market reports:

UK Disposable Hospital Supplies Market Outlook

UK Radioligand Therapy (RLT) Market Analysis

India Surgical Sutures Market Distribution

Italy Ion Chromatography Market Size

UK Soft Tissue Repair Market Share